Your browser doesn't support javascript.
loading
Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models.
Li, Jiulong; Xiao, Yu; Zhang, Yumo; Li, Silu; Zhao, Minzhi; Xia, Tian; Meng, Huan.
Afiliação
  • Li J; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, People's Republic of China.
  • Xiao Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, People's Republic of China.
  • Zhang Y; University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China.
  • Li S; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, People's Republic of China.
  • Zhao M; Department of Environment and Life, Beijing University of Technology, Beijing 100124, People's Republic of China.
  • Xia T; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, People's Republic of China.
  • Meng H; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, People's Republic of China.
ACS Nano ; 17(16): 15354-15370, 2023 08 22.
Article em En | MEDLINE | ID: mdl-37535431

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article